Dale Stephen's Insider Trades & SAST Disclosures
Dale Stephen's most recent trade in Kura Oncology Inc was a trade of 4,825 Common Stock done at an average price of $21.6 . Disclosure was reported to the exchange on Jan. 29, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dale Stephen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.55 per share. | 29 Jan 2024 | 4,825 | 38,817 (0%) | 0% | 21.6 | 103,980 | Common Stock |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 29 Jan 2024 | 4,400 | 46,400 (0%) | 0% | 17.8 | 78,322 | Common Stock |
| Kura Oncology Inc | Dale Stephen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 29 Jan 2024 | 2,758 | 43,642 (0%) | 0% | 17.8 | 49,094 | Common Stock |
| Kura Oncology Inc | Dale Stephen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 23,125 | 50,800 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.87 per share. | 27 Jan 2023 | 4,840 | 27,675 (0%) | 0% | 13.9 | 67,124 | Common Stock |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 27 Jan 2023 | 4,385 | 32,515 (0%) | 0% | 13.9 | 60,909 | Common Stock |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 261,000 | 261,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 36,900 | 36,900 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 100,000 | 100,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Stephen Dale | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 200,000 | 200,000 | - | - | Option to purchase common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges